The single arm phase II CALYPSO study evaluated the efficacy of MET inhibitor savolitinib combined with PD-L1 inhibitor durvalumab in…
CALYPSO
Results of the phase II single arm, multi-site international CALYPSO study point to the efficacy of combining potent MET inhibitor…